A prospective cohort study of Condensed low dose total skin electron beam therapy for mycosis fungoides: reduction of disease burden and improvement in quality of life

Melanoma and Skin Cancer

Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis

JAMA Dermatol

Durgin JS, Jariwala NN, Wysocka M, Zhang KK, Maity A, Benoit B, Plastaras JP, Lewis DJ, Rosenthal JM, Teague JE, Berg S, Del Guzzo C, Kim EJ, Vittorio C, Haun PL, Samimi SS, Villasenor-Park J, Inverso J, Clark RA, Rook AH

doi: 10.1001/jamadermatol.2020.3958

Melanoma and Skin Cancer

Evaluation of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides

JAMA Dermatol.

Vieyra-Garcia P, Fink-Puches R, Porkert S, Lang R, Pöchlauer S, Ratzinger G, Tanew A, Selhofer S, Paul-Gunther S, Hofer A, Gruber-Wackernagel A, Legat F, Patra V, Quehenberger F, Cerroni L, Clark R, Wolf P

doi: 10.1001/jamadermatol.

AcneAlopecia AreataMelanoma and Skin CancerPsoriasis

Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013

JAMA Dermatol.

Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, Nsoesie EO, Ferrari AJ, Erskine HE, Silverberg JI, Vos T, Naghavi M

doi: 10.1001/

Atopic Dermatitis

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

J Eur Acad Dermatol Venereol.

Maksimovic N, Zaric M, Reljic V, Nikolic M, Gazibara T

doi: 10.1111/jdv.15939.

Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone

JAMA Dermatol.

Albers LN, Arbiser JL, Feldman RJ

doi: 10.1001/

Immunotherapy

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017

Eur J Cancer.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R

doi: 10.1016/j.ejca.2017.02.027.

Rheumatoid Arthritis

Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network

Rheumatology (Oxford).

Nikiphorou E, Norton SJ, Carpenter L, Walsh DA, Creamer P, Dixey J, Young A, Kiely PDW

doi: 10.1093/rheumatology/kez461.

Psoriasis

Secukinumab treatment leads to normalisation of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: The PROSE study results

J Eur Acad Dermatol Venereol.

Augustin M, Dauden E, Mrowietz U, Konstantinou MP, Gerdes S, Kingo K, Szepietowski JC, Perrot JL, Cuccia A, Rissler M, Gathmann S, Sieder C, Orsenigo R, Jagiello P, Bachhuber T

doi: 10.1111/jdv.16632.

Further Publications Dermatology

Alemtuzumab, Total Skin Electron Beam, and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Sezary Syndrome: A Retrospective Cohort Study

J Eur Acad Dermatol Venereol

Thompson LL, Pan CX, Chang MS, Molina GE, Chen YB, Barnes JA, Chen ST

doi: 10.1111/jdv.17144

Related content

Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis

Evaluation of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides

Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017

Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network

Secukinumab treatment leads to normalisation of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: The PROSE study results

Alemtuzumab, Total Skin Electron Beam, and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Sezary Syndrome: A Retrospective Cohort Study